Equiparin 5,000 IU/100 g gel for horses

البلد: أيرلندا

اللغة: الإنجليزية

المصدر: HPRA (Health Products Regulatory Authority)

العنصر النشط:

Heparin sodium ; Hydroxyethyl salicylate; Levomenthol

متاح من:

aniMedica GmbH

ATC رمز:

QM02AC99

INN (الاسم الدولي):

Heparin sodium ; Hydroxyethyl salicylate; Levomenthol

جرعة:

5.000 international unit(s)

الشكل الصيدلاني:

Gel

نوع الوصفة الطبية :

POM: Prescription Only Medicine as defined in relevant national legislation

المجموعة العلاجية:

Horses

المجال العلاجي:

preparations with salicylic acid derivatives, combinations

الخصائص العلاجية:

Miscellaneous

الوضع إذن:

Authorised

تاريخ الترخيص:

2010-01-24

خصائص المنتج

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Equiparin 5.000 IU/100 g gel for horses.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
100 g gel contain:
ACTIVE SUBSTANCES:
Heparin sodium
5000 I.U.
Hydroxyethyl salicylate
5.0 g
Levomenthol
0.5 g
EXCIPIENTS:
Chlorophyllin copper (E 141)
0.001 g
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Gel.
Clear green cutaneous gel.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Horses.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of local inflammatory swellings and bruising,
including tendonitis, tenosynovitis, bursitis and other
acute inflammatory conditions of the musculo-skeletal system in the
horse.
Equiparin also promotes the early reabsorption of haematoma and
oedematous swelling resulting from such conditions.
4.3 CONTRAINDICATIONS
Do not use in case of hypersensitivity to the active substances or to
any of the excipients.
Not permitted for use in mares producing milk for human consumption.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_4_
_/_
_1_
_2_
_/_
_2_
_0_
_1_
_4_
_C_
_R_
_N_
_ _
_7_
_0_
_1_
_9_
_2_
_9_
_3_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Avoid contact with the eyes or mucous membranes.
Do not apply to open wounds or skin lesions.
Discontinue if side effects such as signs of discomfort or swelling
occur.
SPE